BreakSight’s vision is to advance precision medicine by uncovering precise maps of DNA damage. Our technology identifies site-specific DNA breakage across the genome from DNA-damaging compounds. Our innovative and comprehensive platform enables discovery of novel DNA biomarkers of drug response by unraveling mechanisms of genomic instability caused by targeted therapeutics.
City of Hope
City of Hope, a world-renowned, National Cancer Institute-designated comprehensive cancer center, has one of the largest geographic footprints in cancer research and treatment, providing cancer patients with timely access to exceptional care, clinical trials and leading-edge innovation.
Inotiv provides a fully integrated drug discovery solution customized to your company’s project goals. We provide pharmacological, toxicological, and in vitro/in vivo assessment across multiple therapeutic areas and species to ensure the right studies are performed at the right time.